Journal of the American Society of Echocardiography
Volume 23, Issue 4 , Pages 377-379, April 2010

Transcutaneous Aortic Valve Implantation—A First Line Treatment for Aortic Valve Disease?

Divisions of Cardiology and Departments of Medicine, St Paul's Hospital and the University of British Columbia, Vancouver, British Columbia, Canada

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Conflicts of interest: Dr Munt has been a paid consultant to Edwards Lifesciences (Irvine, CA). Dr Munt and Mr Moss are investigators in the Placement of Aortic Transcatheter Valve (PARTNER) trial, sponsored by Edwards Lifesciences.

 Editorial Comments published in the Journal of the American Society of Echocardiography (JASE) reflect the opinions of their author(s), and do not necessarily represent the views of JASE, its editors, or the American Society of Echocardiography.

PII: S0894-7317(10)00183-5

doi:10.1016/j.echo.2010.02.017

Journal of the American Society of Echocardiography
Volume 23, Issue 4 , Pages 377-379, April 2010

Article Tools

* Image Usage & Resolution